Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Martin-Sanchez E 

PROVIDER: S-EPMC11321322 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature